| Filing date | Description | Form | View |
|---|---|---|---|
CORRESP |
CORRESP | View HTML | |
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy |
DRS | View HTML | |
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy |
DRS | View HTML | |
EFFECT |
EFFECT | View HTML | |
EFFECT |
EFFECT | View HTML | |
EFFECT |
EFFECT | View HTML | |
Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing |
144 | View HTML | |
Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing |
144 | View HTML | |
Form of prospectus disclosing information facts events covered in both forms 424B1 424B3 |
424B4 | View HTML | |
Form of prospectus disclosing information facts events covered in both forms 424B1 424B3 |
424B4 | View HTML |
Data provided by Kaleidoscope.
2024
2023
2022
2021
Monday, May 20, 2024, at 9:30 AM Pacific Time
Nurix’s 2024 Annual Meeting of Stockholders will be held on Monday, May 20, 2024.
Stockholders of record of Nurix common stock as of the close of business on March 21, 2024, are entitled to vote at the meeting. The live webcast of the meeting will be accessible by visiting www.virtualshareholdermeeting.com/NRIX2024.
Copies of the CEO Letter, Proxy Statement and Annual Report to Shareholders for the 2024 Annual Meeting of Stockholders are available on the “Events and Presentations” page within the “Investors” section of our website.
'